NCT04910802View on ClinicalTrials.gov

Concomitant HPV Vaccination and HPV Screening HPV Infection and Cervical Cancer in Sweden

PHASE4RecruitingINTERVENTIONAL

Enrollment

150,000

Participants

Timeline

Start Date

May 3, 2021

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2027

Conditions

HPV InfectionCIN 2/3Cervical Cancer

Interventions

BIOLOGICAL

Gardasil9

Concomitant vaccination and HPV screening. Gardasil9 will be administered using standard dosage. 1 dose at recruitment and the 2nd dose 3 years later.

Trial Locations (1)

10239

RECRUITING

Cancer prevention, screening, and counseling unit, Regional Cancer Center of Stockholm-Gotland, Stockholm

All Listed Sponsors

collaborator

Karolinska University Hospital

OTHER

lead

Miriam Elfström

OTHER_GOV

NCT04910802 - Concomitant HPV Vaccination and HPV Screening HPV Infection and Cervical Cancer in Sweden | Biotech Hunter | Biotech Hunter